When Halle Berry first experienced symptoms of perimenopause, her doctor misdiagnosed her as having herpes, prompting her to ...

Hormone therapy saves lives, but its hidden costs—sleepless nights, crippling anxiety, and intimacy struggles—leave breast ...

Urinary tract infections (UTIs) are such a pain-literally. Flare-ups are marked by discomfort, pelvic pressure and an ...

Patients with early-stage, node-negative, hormone receptor (HR)-positive, HER2- negative breast cancer who have a high risk of recurrence based on the OncotypeDX genomic test had better outcomes when ...

Imlunestrant worked particularly well in combination with the targeted therapy drug Verzenio. The combo helped women with ...

Hope S. Rugo, MD, FASCO, discusses how the combination of elacestrant and abemaciclib compares with other treatment options for patients with advanced breast cancer, whether estrogen receptor-positive ...

First-in-human results for three investigational inhibitors show anti-tumor activity without unmanageable effects on blood glucose.

A machine learning (ML) model incorporating both clinical and genomic factors outperformed models based solely on either ...

For the clinical trial, researchers recruited 874 women with advanced breast cancer that had either come back or progressed ...

Patients with high-risk, BRCA-positive breast cancer who received olaparib (Lynparza) after standard treatment continued to have better survival outcomes than those who received placebo after a median ...